← Leaderboards
Fyodor D Urnov
Sangamo Biosciences, Inc.
$2,470,630
Attributed
$2,470,630
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,470,630 · 4
By mechanism
U19$2,266,630 · 2
R43$204,000 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Reporting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReportingManagement Information SystemsLaboratoriesReagentNervous System DisorderPathogenicityExcisionGenomicsMonitorProgramsSafetyResourcesSpecimenResearch Project GrantsAllelesEnsureCollaborationsGenome EditingLeadCell LineChargeCellsBiological ModelsCell Model
Grant awards (6)
Administrative Core$623,888
U19 · FY2025 · NS · contact PI
Resource Core I: Genomic Outcomes Core$623,888
U19 · FY2025 · NS · contact PI
Resource Core I: Genomic Outcomes Core$714,766
U19 · FY2024 · NS · contact PI
Administrative Core$304,088
U19 · FY2024 · NS · contact PI
ZFN-driven Gene Disruption of CCR5 as a Potential Treatment of AIDS$100,000
R43 · FY2006 · AI · contact PI
Using Enhanced Gene Targeting to Repair the Sickle Cell$104,000
R43 · FY2004 · HL